BACKGROUND: Metabolic syndrome (MS) is associated with dyslipidemia, and insulin resistance (IR) may be a main determinant of this dyslipidemia. OBJECTIVE: To determine how lipoprotein particle concentration and size are related to MS and IR in a population-based sample of Alaska Eskimos. DESIGN: Participants underwent a physical exam, personal interview, collection of biological specimens, and diagnostic tests. SETTING: This study was conducted in the Norton Sound region of Alaska. PARTICIPANTS: One thousand one hundred fifty-eight Inupiat Eskimo adults (women=653, men=505). MAIN OUTCOME MEASURES: Lipoprotein particle profile was evaluated by nuclear magnetic resonance (NMR) and related to presence of MS and level of IR. RESULTS: Participants with MS had (a) significantly higher concentrations of all VLDLs and a larger VLDL size (women, p=0.007; men, p=0.0001); (b) higher concentrations of small LDL (women, p<0.0001; men, p=0.09) and lower concentrations of large LDL (women, p<0.0001), leading to a smaller overall LDL size (women, p<0.0001; men, p<0.05); (c) significantly lower concentrations of large HDL (both genders, p<0.0001) and an increase in intermediate (women, p<0.05) and small HDL (women, p<0.0001; men, p<0.004). Lipoprotein profile with increasing HOMA-IR resembled that of individuals with MS. CONCLUSIONS: In this population MS is characterized by lipoprotein distribution and size abnormalities independent of obesity, age, and other cardiovascular risk factors, including lipid concentration. IR seems the major determinant.
BACKGROUND:Metabolic syndrome (MS) is associated with dyslipidemia, and insulin resistance (IR) may be a main determinant of this dyslipidemia. OBJECTIVE: To determine how lipoprotein particle concentration and size are related to MS and IR in a population-based sample of Alaska Eskimos. DESIGN:Participants underwent a physical exam, personal interview, collection of biological specimens, and diagnostic tests. SETTING: This study was conducted in the Norton Sound region of Alaska. PARTICIPANTS: One thousand one hundred fifty-eight Inupiat Eskimo adults (women=653, men=505). MAIN OUTCOME MEASURES: Lipoprotein particle profile was evaluated by nuclear magnetic resonance (NMR) and related to presence of MS and level of IR. RESULTS:Participants with MS had (a) significantly higher concentrations of all VLDLs and a larger VLDL size (women, p=0.007; men, p=0.0001); (b) higher concentrations of small LDL (women, p<0.0001; men, p=0.09) and lower concentrations of large LDL (women, p<0.0001), leading to a smaller overall LDL size (women, p<0.0001; men, p<0.05); (c) significantly lower concentrations of large HDL (both genders, p<0.0001) and an increase in intermediate (women, p<0.05) and small HDL (women, p<0.0001; men, p<0.004). Lipoprotein profile with increasing HOMA-IR resembled that of individuals with MS. CONCLUSIONS: In this population MS is characterized by lipoprotein distribution and size abnormalities independent of obesity, age, and other cardiovascular risk factors, including lipid concentration. IR seems the major determinant.
Authors: B Lamarche; A Tchernof; S Moorjani; B Cantin; G R Dagenais; P J Lupien; J P Després Journal: Circulation Date: 1997-01-07 Impact factor: 29.690
Authors: David S Freedman; James D Otvos; Elias J Jeyarajah; Irina Shalaurova; L Adrienne Cupples; Helen Parise; Ralph B D'Agostino; Peter W F Wilson; Ernst J Schaefer Journal: Clin Chem Date: 2004-04-23 Impact factor: 8.327
Authors: Michael Y Tsai; Angeliki Georgopoulos; James D Otvos; Jose M Ordovas; Naomi Q Hanson; James M Peacock; Donna K Arnett Journal: Clin Chem Date: 2004-05-13 Impact factor: 8.327
Authors: Z Gordon Jiang; Ian H de Boer; Rachel H Mackey; Majken K Jensen; Michelle Lai; Simon C Robson; Russell Tracy; Lewis H Kuller; Kenneth J Mukamal Journal: Metabolism Date: 2015-10-22 Impact factor: 8.694
Authors: Maria Masulli; Lidia Patti; Gabriele Riccardi; Olga Vaccaro; Giovanni Annuzzi; Sven O E Ebbesson; Richard R Fabsitz; Wm James Howard; James D Otvos; Mary J Roman; Hong Wang; Neil J Weissman; Barbara V Howard; Angela A Rivellese Journal: Am J Cardiol Date: 2009-10-14 Impact factor: 2.778
Authors: Zhenghui G Jiang; Elliot B Tapper; Margery A Connelly; Carolina F M G Pimentel; Linda Feldbrügge; Misung Kim; Sarah Krawczyk; Nezam Afdhal; Simon C Robson; Mark A Herman; James D Otvos; Kenneth J Mukamal; Michelle Lai Journal: Liver Int Date: 2016-02-24 Impact factor: 5.828
Authors: Giovanni Annuzzi; Angela A Rivellese; Hong Wang; Lidia Patti; Olga Vaccaro; Gabriele Riccardi; Sven Oe Ebbesson; Anthony G Comuzzie; Jason G Umans; Barbara V Howard Journal: Am J Clin Nutr Date: 2012-05-09 Impact factor: 7.045
Authors: Mehmet Emre Taşcılar; Tolga Özgen; Murat Cihan; Ayhan Abacı; Ediz Yeşilkaya; Ibrahim Eker; Muhiddin Serdar Journal: J Clin Res Pediatr Endocrinol Date: 2010-05-02
Authors: Aline Jelenkovic; Leonie H Bogl; Richard J Rose; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Jaakko Kaprio; Karri Silventoinen Journal: Atherosclerosis Date: 2014-01-21 Impact factor: 5.162